Popular weight-loss drugs may lower cancer risk, finds large study

Exciting new findings indicate that GLP-1 weight-loss medications might dramatically reduce the likelihood of 10 types of cancer linked to obesity for patients with type 2 diabetes, outperforming insulin. However, there’s no observed benefit for postmenopausal breast or thyroid cancers.

Leave a Reply

Your email address will not be published. Required fields are marked *